Biobusiness Development
Think Europe, think Biovalley!
In the heart of Europe, bringing together three regions from France, Germany and Switzerland, BioValley is one of the leading European Life Sciences regions in the world. Are you developing innovative projects in Life Sciences or wishing to locate in Europe, come and meet the BioValley Cluster!
-
NEW GRANT FOR DOMAIN THERAPEUTICS
Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the receipt of a second grant of 230 000 dollars (USD) from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support its metabotropic glutamate receptor type III positive allosteric modulators program. The MJFF first supported the initial stages of this program in 2012 through a 300 000 dollars (USD) grant. -
FREIBURG SCIENTIST IS AWARDED THE PAUL EHRLICH PRIZE 2014
Prof. Dr Michael Ret
h has won the Paul Ehrlich and Ludwig Darmstaedter Prize 2014 for his research on the immune system. Dr Reth is Professor for Molecular Immunology at the Institute of Biology III of the University of Freiburg and Scientific Director of the Cluster of Excellence BIOSS. He is also head of the department for Molecular Immunology at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE). This prize is endowed with € 100,000 and is one of the highest honours in science in Germany. -
Rhenovia Pharma secures Series B funding
The company raises EUR 540,000 (USD 738, 000) from historical shareholders to expand its staff Rhenovia, the world leader in biosimulation of the central nervous system, plans to raise a further EUR 2 million in 2014 to step up development in its three key markets of medicinal products, agrifood and neurotoxicity -
“TIGER” ROAMING THE RHINE VALLEY
T
he Bernstein Center Freiburg hosts a new project, strengthening the research of neurological diseases from the perspective of theoretical neurosciences. Within the “Trinational Initiative on Brain Diseases” (TIGER) scientists from Freiburg, Strasbourg and Basel investigate the neuronal networks involved in several brain diseases. They place special emphasis on such conditions as movement disorders, epilepsy, and anxiety. The project is co-funded from 2012 until 2015 by the European Union within its INTERREG framework. -
MICHAEL N. HALL, PROFESSOR AT THE UNIVERSITY OF BASEL’S BIOZENTRUM AWARDED THIS YEAR’S MARCEL BENOIST PRIZE
The prize is being awarded to Hall for his ground-breaking studies in the field of cell biology on cell growth and the development of cancer. As a young assistant professor at the Biozentrum in the 1990′s, Hall discovered a protein that controls cell growth and size in the context of his work on simple organisms, in particular yeasts. It soon became clear to him that this mechanism was also present in complex organisms such as mammals and humans and was vital to the life processes of cells and organs.
BioValley
the Place to be
BioValley is teeming with advantages for all players in Life Sciences who are searching to settle down and develop in the European BioValley region.
Discover BioValley
Players Database!
BioValley offers a unique combination of scientific talents in academia as well as in industry.
Let’s discover all BioValley key players through our online Database!
BioValley
Services & Events
The BioValley cluster is your one-stop contact for all project development and locating in the BioValley region. Discover how BioValley can help you and take part to our network / business events: see our annual event schedule!
